PSA lacks adequate sensitivity and specificity in distinguishing PCa and non-malignant prostate lesions, such as benign prostatic hyperplasia (BPH) and prostatitis, requiring other supportive diagnostic approaches in the clinic [38]. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.